Effect of Shi-Zhen-An-Shen herbal formula granule in the treatment of young people at ultra-high risk for psychosis
A pilot study
Bibliographic Data
| ID | 15525502 |
|---|---|
| Authors | Hong Zhu (0000-0003-0795-8329, Capital Medical University), Yanzhe Ning (0000-0002-6439-522X, Capital Medical University), Sisi Zheng (0000-0003-1676-6855, Beijing Anding Hospital), Sitong Feng (0000-0003-1819-9241, Capital Medical University), Linrui Dong (0000-0002-8605-5322, Beijing Anding Hospital), Hongxiao Jia (0000-0002-4924-1388, Capital Medical University, corresponding author) |
| Year | 2023 |
| Volume | 14 |
| Pages | 1160452-1160452 |
| Publication date | 2023-06-27 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2023.1160452 |
| PMID | 37441142 |
| OpenAlex | W4382246943 |
| Language | EN |
| References cited | 35 |
SZAS-HFG can effectively alleviate psychosis symptoms, and improve cognitive impairments and overall functioning as well as aripiprazole. Clinical trial registration: Chinese Clinical Trial Registry, ChiCTR-IOR-17013513
Alternative medicine · Aripiprazole · Cognition · Global Assessment of Functioning · Outpatient clinic · Placebo · Psychiatry · Psychosis · Randomized controlled trial · Schizophrenia (object-oriented programming · Verbal learning · Verbal memory · Clinical Psychology · Medicine · Mental Health and Psychiatry · Schizophrenia research and treatment · Tryptophan and brain disorders · Internal Medicine
| Highly cited | No |
|---|